Sacituzumab or Chemo in First-Line TNBC: Which Is Better? ...Middle East

Medscape - News
Sacituzumab or Chemo in First-Line TNBC: Which Is Better?
Pembrolizumab with sacituzumab govitecan instead of chemotherapy led to improved progression-free survival in PD-L1-postive locally advanced or metastatic triple-negative breast cancer. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Sacituzumab or Chemo in First-Line TNBC: Which Is Better? )

Also on site :